© Copyright Our Wall
The present treatment landscape of chronic wound and bone healing is characterized by a variety of unmet needs; tissue engineering-based regeneration products have emerged as a viable therapeutic option, which is capable of catering to the growing demand
Roots
Analysishas announced the addition of “Tissue
Engineering-based Regeneration Products Market, 2022-2035” report to its list
of offerings.
Given the ever-increasing demand for
tissue transplantation, primarily for wound and bone
healing, there is an urgent need for safe and
efficient products that enable healing and regeneration. At present, the supply
of tissue donations is insufficient to satisfy the required demand. It is worth
highlighting that, in recent years, tissue engineering and regenerative
medicinehave emerged as promising alternatives
for tissue regeneration.
To
request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/tissue-engineering-market/request-sample.html
Key Market Insights
Over 115 tissue
engineering-based skin regeneration products
are presently available in this market space
About 50% of the total products are
intended for wound healing, followed by developed for the purpose of surgical
healing. Further, more than 50% of the products are made of human placental
tissues, followed by those developed using other animal-based tissues.
~40 tissue engineering-based bone
regeneration products are being offered by developers, globally
About 55% of the total products are
made from bone tissues, followed by those developed using stem cells. In fact,
most of the products are formulated in the form of a sheet (10), followed by
those developed in the form of a bone matrix. Further, nearly 75% of the
products are available in the form of xenografts.
Around 60 players are engaged in the
development of the tissue engineering-based regeneration products
Majority of the players engaged in this
domain are mid-sized firms (51-500 employees, 31%), followed by small
players (11-51 employees, 27%), large players (1000-5000 employees,
26%) and very small (2-10 employees, 10%) companies. It is worth
noting that ~40% developersare based in North America.
Till date, 750+ grants have been
awarded for tissue engineering-based regeneration products
For research and development activity
of tissue engineering-based regeneration products, grant amount of close to USD
300 million has been awarded in last five years. Further, 70% of this amount
was awarded in 2021 alone.
Patent activity in this domain has
grown at a CAGR of ~11%, between 2012 and 2022
R&D activity related to tissue
engineering-based regeneration products is largely concentrated in North
America; this can be validated from the fact that about 40% of the total
patents were filed in this region, followed by the World Intellectual Property
Organization (30%) and Asia-Pacific region (20%).
More than USD 2 billion Invested by
industry and non-industry stakeholders in the last five years
Majority of the companies primarily
received funding through private placements (~25%) and debt financing (~20%)
rounds. It is worth mentioning that, over 95% of the amount was invested in
companies based in North America.
Partnership
activity in this domain has increased at a CAGR of ~25%, between 2017 and 2022
Large companies have inked the highest
number of partnerships related to tissue engineering-based regeneration
products, In addition nearly 40% majority of the agreements reported in tissue
engineering marketwere instances of
mergers and acquisitions.
North America is
expected to capture more than 55% share in the tissue engineering-based
regeneration products market by 2035
In terms of area of application, the
current market is anticipated to be driven by products intended for skin
healing (~50%), followed by those targeting bone healing (~30%). Further,
xenograft-based products are expected to grow at a relatively faster pace
(10.58%), till 2035.
Key Questions Answered
§ Who are the leading players
engaged in providing tissue engineering-based regeneration products?
§ Which tissue
engineering-based regeneration product is most commonly offered by developers?
§ What is the relative
competitiveness of tissue engineering-based regeneration product providers?
§ What types of partnership
models are commonly being adopted by stakeholders in this industry?
§ What is the trend for
capital investments in the tissue engineering-based regeneration products
market?
§ How has the patent landscape
in this domain evolved over the last two decades?
§ What is the overall trend of
grant activity related to tissue engineering-based regeneration products?
§ Which key market trends and
driving factors are likely to impact the growth of the tissue engineering-based
regeneration products market?
§ How is the current and
future market opportunity likely to be distributed across key market segments?
The financial opportunity within the
tissue engineering-based regeneration devices has been analyzed across the
following segments:
§ Type
of Graft
§ Allografts
§ Autografts
§ Xenografts
§ Area
of Application
§ Bone
Healing
§ Burn
Healing
§ Wound
Healing
§ Surgical
Healing
§ Others
§ Key
Geographical Regions
§ Ambulatory
Surgical Centers
§ Hospitals
§ Specialty Clinics
§ Key
Geographical Regions
§ North
America
§ Europe
§ Asia
§ Middle
East and North Africa
§ Latin
America
§ Rest
of the World
The
research includes profiles of key players (listed below); each profile
features a brief overview of the company, details related to its recent
developments (including funding and collaborations) and an informed
future outlook.
§ AlloSource
§ Bio-Tissue
§ Integra
LifeSciences
§ MiMedx
§ Organogenesis
§ Smith+Nephew
§ Tissue
Regenix
§ VIVEX
Biologics
For additional details, please visit https://www.rootsanalysis.com/reports/tissue-engineering-market.html
You may also be interested in the
following titles:
1. Quantum
Computing in Drug Discovery Services Market : - Industry Trends and
Global Forecasts, 2023-2035
2. Viral
Clearance and Viral Testing Services Market : - Industry Trends and
Global Forecasts, 2023-2035
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market
research. Having worked with over 750 clients worldwide, including Fortune 500
companies, start-ups, academia, venture capitalists and strategic investors for
more than a decade, we offer a highly analytical / data-driven perspective to a
network of over 450,000 senior industry stakeholders looking for credible
market insights.
Contact:
Ben Johnson
+1 (415) 800
3415
[email protected]
The Wall